![]() Alexion Pharmaceuticals Alexion (also known as Alexion, AstraZeneca Rare Disease) is a biopharmaceutical company engaged in therapies for rare diseases. | Crinetics Pharmaceuticals Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors. | |
Founding Date | Founding Date 1992 | Founding Date 2008 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boston, US HQ Frenchs Forest, AU Wien, AT Elsene, BE São Paulo, BR Vaughan, CA Shanghai, CN see more | Locations San Diego, US HQ |
Employees | Employees 10,6006% increase | Employees 43751% increase |
Valuation ($) | Valuation ($) 40.3 b | Valuation ($) 5.1 b |
Financial | ||
Revenue (est.) | Revenue (est.) $6.1b (FY, 2020) | Revenue (est.) $7.7m (FY, 2025) |
Cost of goods | Cost of goods $553.5m (FY, 2020) | Cost of goods $1.1m (FY, 2025) |
Gross profit | Gross profit $5.5b (FY, 2020) | Gross profit $6.6m (FY, 2025) |
Net income | Net income $603.4m (FY, 2020) | Net income ($465.3m) (FY, 2025) |
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company that develops and commercializes therapeutics for rare endocrine diseases and endocrine-related tumors.
View company